Company / R&D per Share
Vera Therapeutics, Inc. R&D per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$3.35
FY2025
5-year range
$1.67 / $3.35
FY2021-FY2025
Trend
+46.9%
vs FY2024
Sector context
#62 of 208
Health Care
What the data says
At $3.35, Vera Therapeutics, Inc.'s r&d per share ranks #62 of 208 in the Health Care sector. R&D per Share has fluctuated over the past 6 years, ranging from $1.67 in FY2021 to $141.29 in FY2020.
Based on SEC 10-K filings.
3.35 in FY2025 with a 5-year CAGR of -52.7%.
Improved from $1.83 to $3.35 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +8.9%
- 5-Year CAGR
- -52.7%
- 10-Year CAGR
- -
Sector benchmark
#62 of 208 in Health CareTop 30% of 208This company $3.35 Sector average $28.82
▼
-88.4% below sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 46.9% year-over-year.
- Ranks #62 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2020.
- Lowest r&d per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.35 | +46.9% |
| FY2024 | $2.28 | +24.5% |
| FY2023 | $1.83 | -29.5% |
| FY2022 | $2.60 | +55.2% |
| FY2021 | $1.67 | -98.8% |
| FY2020 | $141.29 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026